Regen BioPharma Inc 8-K

What Happened
Regen BioPharma, Inc. announced on January 19, 2026 that its Board declared a stock dividend payable in Series A Preferred Stock. Shareholders of record on February 3, 2026 will receive the dividend on or about February 9, 2026. The dividend is payable in shares of Regen’s authorized but unissued Series A Preferred Stock.

Key Details

• Dividend declared: one (1) share of Series A Preferred Stock issued for every one (1) share owned as of the Record Date.
• Applicable to: each share of Common Stock, each share of Series A Preferred, Series AA Preferred, Series M Preferred, and Series NC Preferred held as of Feb 3, 2026.
• Record Date: February 3, 2026; Payment Date: on or about February 9, 2026.
• Security issued: Series A Preferred Stock (authorized but previously unissued).

Why It Matters
This action will increase the number of Series A Preferred shares outstanding and changes Regen’s capitalization mix. For investors, that can affect the company’s equity structure and any rights tied to Series A Preferred shares (voting, liquidation preference, dividends, conversion terms). Shareholders should review Regen’s disclosures about the Series A Preferred terms and monitor company updates for any additional details about rights or potential effects on common shares.